Ten post jest także dostępny w języku: polski
Donatory Limited, a subsidiary of Abris CEE Mid-Market III LP, managed by Abris Capital Partners, will buy 100% of shares in Scanmed SA from the South African Life Healthcare group. The acquisition agreement was signed on Tuesday. The Office of Competition and Consumer Protection (UOKiK) approval is still needed.
Abris invests in health and sees great potential in this industry
The first information about a possible sale of Scanmed appeared already in 2019, and at the beginning of 2020 there was even speculation about who might be a potential buyer of shares – more on that here. Now everything is clear, as on 24 November 2020. Donatory Limited, a subsidiary of Abris CEE Mid-Market III LP fund, managed by Abris Capital Partners, signed an agreement with Dadley Investments Sp. z o.o., a subsidiary of the Life Healthcare group, to acquire 100% of Scanmed SA shares.
It is worth adding that health care seems to have still a great potential for development in the long term, especially in the context of the COVID-19 pandemic. What is important, we notice an increase in public financing for the entire health care sector along with a dynamically developing commercial market, which is strongly influenced by the outbreak of the coronavirus pandemic – emphasises Sylwester Urbanek, Director at Abris Capital Partners, quoted in the official announcement of the fund.
Scanmed development plans
Scanmed is listed among the largest private healthcare entities in Poland. Currently, Scanmed operates both in the hospital and outpatient segment. However, the scale of its activity is smaller than that of the largest private medical companies. The company’s facilities are located in 42 locations throughout Poland.
Among other things, Scanmed intends to intensify its development in the field of orthopaedics, ophthalmology, rehabilitation and uroginekology. The company also plans to open new laboratories and surgical wards. Abris Capital Partners will support Scanmed in expanding its range of services, as well as in improving its medical infrastructure and healthcare in key therapeutic areas, it was informed.